Washington D.C. – Today, the American Free Enterprise Chamber of Commerce (AmFree Chamber) issued the following statement praising the report issued by U.S. Sen. Bill Cassidy (R., La.), chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, spotlighting the rampant abuse in the Federal 340B Drug Pricing Program:
“With its lack of transparency and potential for abuse, 340B is the perfect example of Washington dysfunction,” said Gentry Collins, CEO of the AmFree Chamber. “We applaud Chairman Cassidy for shining a light on the waste, fraud, and abuse in the system, which, combined with President Trump’s executive order to lower drug prices, highlights the urgency for comprehensive federal reform. Let’s hope they get it done.”
Sen. Cassidy’s findings were first reported on by the Washington Reporter.
###
About AmFree Chamber
The American Free Enterprise Chamber of Commerce (AmFree Chamber) is a trade organization representing American businesses of all sizes. It is dedicated to advancing the principles of free enterprise, free markets, limited government, and American leadership globally. AmFree Chamber is chaired by the Honorable Terry E. Branstad, who previously served as Ambassador to China and was the longest serving Governor in American history.
AmFree Chamber has members representing dozens of industries and from across the United States. Since its founding in 2022, AmFree Chamber has aggressively represented its members’ interests through legislative outreach, regulatory comments, and judicial briefing.